Clinical Trial Update: Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing the renal effects of DPP-4 inhibitors versus sulfonylureas in type 2 diabetes patients with proteinuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proteinuria
• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitors
• Sulfonylureas

Snippet

Sponsor: Changhua Christian Hospital | Conditions: Type 2 Diabetes Mellitus, Proteinuria | Phase 4 | Status: COMPLETED